Century Therapeutics, Inc. (IPSC) Misses Q3 EPS by 1c

Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q3 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• EyePoint Inc. (EYPT) PT Lowered to $8 at Jefferies
• Goldman Sachs closes short THB/INR trade for small gain